Cargando…
Pre-clinical Models of Metastasis in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a hostile solid malignancy coupled with an extremely high mortality rate. Metastatic disease is already found in most patients at the time of diagnosis, resulting in a 5-year survival rate below 5%. Improved comprehension of the mechanisms leading to metast...
Autores principales: | Miquel, Maria, Zhang, Shuman, Pilarsky, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578999/ https://www.ncbi.nlm.nih.gov/pubmed/34778259 http://dx.doi.org/10.3389/fcell.2021.748631 |
Ejemplares similares
-
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022) -
CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019) -
LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis
por: Liu, Xinjian, et al.
Publicado: (2021) -
Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer
por: van Roey, Ruthger, et al.
Publicado: (2021) -
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
por: Zhou, Xu, et al.
Publicado: (2021)